Stakeholders Want a Menu of Choices: Findings from a Consultation Workshop on Improving Access to Secondary Prophylaxis of Rheumatic Fever and Rheumatic Heart Disease
References
- World Health Organization. WHO guideline on the prevention and diagnosis of rheumatic fever and rheumatic heart disease. Geneva; 2024. Available from:
https://iris.who.int/server/api/core/bitstreams/fbd835e1-b9b7-414a-b6aa-9c279472bbdf/content [Accessed 23/04/2026]. - RHD Action. Global status of BPG report. 2016. Available from:
https://rhdaction.org/resources/global-status-bpg-report [Accessed 24/05/2024]. - Ryan B. Antibiotic shortage could worsen syphilis epidemic. The New York Times. 2023 [Internet]. Available from:
https://www.nytimes.com/2023/07/07/health/syphilis-epidemic-antibiotic-shortage-pfizer.html [Accessed 14/05/2025]. - Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, Bonny A. Global burden of cardiovascular diseases and risk factors, 1990–2019: Update from the GBD 2019 study. Journal of the American College of Cardiology. 2020;76(25):2982–3021. DOI: 10.1016/j.jacc.2020.11.010
- Wyber R, Taubert K, Marko S, Kaplan EL. Benzathine penicillin G for the management of RHD: Concerns about quality and access, and opportunities for intervention and improvement. Global Heart. 2013;8(3):227–234. DOI: 10.1016/j.gheart.2013.08.011
- Hirani K, Rwebembera J, Webb R, Beaton A, Kado J, Carapetis J, Bowen A. Acute rheumatic fever. The Lancet. 2025;405(10495):2164–2178. DOI: 10.1016/S0140-6736(25)00185-0
- Remenyi B, Carapetis J, Wyber R, Taubert K, Mayosi BM, World Heart F. Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease. Nature Reviews Cardiology. 2013;10(5):284–292. DOI: 10.1038/nrcardio.2013.34
- World Health Organization. Model list of essential medicines. Available from:
https://www.list.essentialmeds.org/ [Accessed 25/03/2026]. - Wyber R, Pearson G, Manning L. Shortages of benzathine benzylpenicillin G in Australia highlight the need for new sovereign manufacturing capability. The Medical Journal of Australia. 2025;222(5):223–225. DOI: 10.5694/mja2.52590
- Nurse-Findlay S, Taylor MM, Savage M, Mello MB, Saliyou S, Lavayen M, Seghers F, Campbell ML, Birgirimana F, Ouedraogo L, Newman Owiredu M. Shortages of benzathine penicillin for prevention of mother-to-child transmission of syphilis: An evaluation from multi-country surveys and stakeholder interviews. PLoS Medicine. 2017;14(12):
e1002473 . DOI: 10.1371/journal.pmed.1002473 - Seghers F, Taylor MM, Storey A, Dong J, Wi TC, Wyber R, Ralston K, Nguimfack BD. Securing the supply of benzathine benzylpenicillin: A global perspective on risks and mitigation strategies to prevent future shortages. International Health. 2024;16(3):279–282. DOI: 10.1093/inthealth/ihad087
- World Health Organization.
World Health Organization Model List of Essential Medicines. 23rd list . In The selection and use of essential medicines 2023: Executive summary of the report of the 24th WHO Expert Committee on the Selection and Use of Essential Medicines. Geneva; 2023. Available from:https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2023.02 [Accessed 21/05/2024]. - Ali SKM. Implementing the World Health Organization guidelines for rheumatic heart disease in highly endemic settings: Balancing evidence with reality. Global Heart. 2026;21(1):9. DOI: 10.5334/gh.1527
- Francis JR, Wyber R, Remenyi B, Croser D, Carapetis J. Myositis complicating benzathine penicillin-G injection in a case of rheumatic heart disease. IDCases. 2016;4:6–7. DOI: 10.1016/j.idcr.2016.02.001
- Bowen AC, Tong SY, Andrews RM, O’Meara IM, McDonald MI, Chatfield MD, Currie BJ, Carapetis JR. Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: An open-label, randomised, controlled, non-inferiority trial. The Lancet. 2014;384(9960):2132–2140. DOI: 10.1016/S0140-6736(14)60841-2
- Hand RM, Senarathna S, Page-Sharp M, Gray K, Sika-Paotonu D, Sheel M, Chuang VT, Martinez J, Luna G, Manning L, Wyber R. Quality of benzathine penicillin G: A multinational cross-sectional study. Pharmacology Research & Perspectives. 2020;8(6):
e00668 . DOI: 10.1002/prp2.668 - Marantelli S, Hand R, Carapetis J, Beaton A, Wyber R. Severe adverse events following benzathine penicillin G injection for rheumatic heart disease prophylaxis: Cardiac compromise more likely than anaphylaxis. Heart Asia. 2019;11(2):
e011191 . DOI: 10.1136/heartasia-2019-011191 - Birru EM, Alene KA, Manning L, Batty KT, Moore BR. Severe adverse reactions to benzathine penicillin G in rheumatic heart disease: A systematic review and meta-analysis. PLoS One. 2025;20(5):
e0322873 . DOI: 10.1371/journal.pone.0322873 - Sanyahumbi A, Ali S, Benjamin IJ, Karthikeyan G, Okello E, Sable CA, Taubert K, Wyber R, Zuhlke L, Carapetis JR, Beaton AZ. Penicillin reactions in patients with severe rheumatic heart disease: A Presidential Advisory from the American Heart Association. Journal of the American Heart Association. 2022;11(5):
e024517 . DOI: 10.1161/JAHA.121.024517 - Webb R, Wheeler M, Peat B, Lund M, Luey C, Briggs S, Ross MA, Paku B, Anderson P, Zhong N, Lore D. Aotearoa New Zealand clinicians respond to the 2022 American Heart Association Presidential Advisory Statement regarding penicillin reactions in people with severe rheumatic heart disease. The New Zealand Medical Journal (Online). 2023;136(1586):9–11. DOI: 10.26635/6965.e1586
- Birru EM, Batty KT, Manning L, Enkel SL, Moore BR. Acceptability and implementation challenges of benzathine penicillin G secondary prophylaxis for rheumatic heart disease in Ethiopia: A qualitative study. Global Heart. 2025;20(1):8. DOI: 10.5334/gh.1393
- RHD Australia (ARF/RHD writing group). The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (3.2 Edition, March 2022); 2020. Available from:
https://www.rhdaustralia.org.au/system/files/fileuploads/arf_rhd_guidelines_3.2_edition_march_2022.pdf [Accessed 14/05/2024]. - Wyber R, Boyd BJ, Colquhoun S, Currie BJ, Engel M, Kado J, Karthikeyan G, Sullivan M, Saxena A, Sheel M, Steer A. Preliminary consultation on preferred product characteristics of benzathine penicillin G for secondary prophylaxis of rheumatic fever. Drug Delivery and Translational Research. 2016;6(5):572–578. DOI: 10.1007/s13346-016-0313-z
- Kado J, Salman S, Hla TK, Enkel S, Henderson R, Hand RM, Hort A, Page-Sharp M, Batty K, Moore BR, Bennett J. Subcutaneous infusion of high-dose benzathine penicillin G is safe, tolerable, and suitable for less-frequent dosing for rheumatic heart disease secondary prophylaxis: A phase 1 open-label population pharmacokinetic study. Antimicrobial Agents and Chemotherapy. 2023;67(12):
e0096223 . DOI: 10.1128/aac.00962-23 - Cooper J, Enkel SL, Moodley D, Dobinson H, Andersen E, Kado JH, Barr RK, Salman S, Baker MG, Carapetis JR, Manning L. “Hurts less, lasts longer”; a qualitative study on experiences of young people receiving high-dose subcutaneous injections of benzathine penicillin G to prevent rheumatic heart disease in New Zealand. PLoS One. 2024;19(5):
e0302493 . DOI: 10.1371/journal.pone.0302493 - Enkel SL, Kado J, Hla TK, Salman S, Bennett J, Anderson A, Carapetis JR, Manning L. Qualitative assessment of healthy volunteer experience receiving subcutaneous infusions of high-dose benzathine penicillin G (SCIP) provides insights into design of late phase clinical studies. PLoS One. 2023;18(4):
e0285037 . DOI: 10.1371/journal.pone.0285037 - Kado JH, Salman S, Henderson R, Hand R, Wyber R, Page-Sharp M, Batty K, Carapetis J, Manning L. Subcutaneous administration of benzathine benzylpenicillin G has favourable pharmacokinetic characteristics for the prevention of rheumatic heart disease compared with intramuscular injection: A randomized, crossover, population pharmacokinetic study in healthy adult volunteers. Journal of Antimicrobial Chemotherapy. 2020;75(10):2951–2959. DOI: 10.1093/jac/dkaa282
- Russell K, Nicholson R, Naidu R. Reducing the pain of intramuscular benzathine penicillin injections in the rheumatic fever population of Counties Manukau District Health Board. Journal of Paediatrics and Child Health. 2014;50(2):112–117. DOI: 10.1111/jpc.12400
- Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. The Lancet Infectious Diseases. 2005;5(11):685–694. DOI: 10.1016/S1473-3099(05)70267-X
- Ilievski J, Mirams O, Trowman R, Barr RK, Manning L. Patient preferences for prophylactic regimens requiring regular injections in children and adolescents: A systematic review and thematic analysis. BMJ Paediatrics Open. 2024;8(1):
e002450 . DOI: 10.1136/bmjpo-2023-002450 - Barr RK, Barber BW, Tait JR, Landersdorfer CB, Salman S, Musk GC, Page-Sharp M, Batty KT, Kado J, Manning L, Carapetis JR. Development of a sustained release implant of benzathine penicillin G for secondary prophylaxis of rheumatic heart disease. European Journal of Pharmaceutics and Biopharmaceutics. 2023;189:240–250. DOI: 10.1016/j.ejpb.2023.06.006
- Yadav P. Executive order to lower U.S. Drug prices could hurt the poorest countries. Think Global Health; 2025. Available from:
https://www.thinkglobalhealth.org/article/executive-order-lower-us-drug-prices-could-hurt-poorest-countries [Accessed 25/03/2026]. - Sullivan SD, Grueger J, Martin K. International reference pricing comes to America: The MFN policies explained. Value & Outcomes Spotlight. 2026;12(1).
- Danzon PM, Epstein AJ. Effects of regulation on drug launch and pricing in interdependent markets. National Bureau of Economic Research (NBER Working Paper 14041); 2011. Available from:
https://www.nber.org/papers/w14041 [Accessed 25/03/2026].
DOI: https://doi.org/10.5334/gh.1555 | Journal eISSN: 2211-8179
Language: English
Page range: 39 - 39
Submitted on: Jun 17, 2025
Accepted on: Apr 29, 2026
Published on: May 18, 2026
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2026 Thel K. Hla, Stephanie L. Enkel, Joseph Kado, Elizabeth Eadie-Mirams, Rosemary Wyber, Jonathan Carapetis, Laurens Manning, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.